pfe

Pfizer's Q3 Earnings Beat Estimates, Raising Earnings for Full-Year 2017

Pfizer's Q3 Earnings Beat Estimates, Raising Earnings for Full-Year 2017

Pfizer Inc. (NYSE: PFE), the largest U.S. drug maker, posted its financial results for the third quarter on Tuesday. The company also adjusted its guidance for full-year 2017 in the statement. Shares of Pfizer rose to $35.24 per share in premarket t..

National Institute of Health partners with 11 Biopharma companies for Cancer Research

National Institute of Health partners with 11 Biopharma companies for Cancer Research

The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..

Pfizer Considers the Sales of its Consumer Healthcare Business

Pfizer Considers the Sales of its Consumer Healthcare Business

On Tuesday, Pfizer Inc. (NYSE: PFE), the pharmaceutical giant, said that it is considering the sale or spin-off of its consumer healthcare business, whose brands include lip balm Chapstick and painkiller Advil.The company’s consumer healthcare..